Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants

被引:0
|
作者
Yan-Jun Xu
Paramjit S. Tappia
Nirankar S. Neki
Naranjan S. Dhalla
机构
[1] St. Boniface Hospital Research,Department of Physiology, Institute of Cardiovascular Sciences, Faculty of Medicine, University of Manitoba
[2] St. Boniface Hospital Research,Asper Clinical Research Institute
来源
Heart Failure Reviews | 2014年 / 19卷
关键词
Oxidative stress; Atherosclerosis; Resveratrol; Cardiovascular disease; Diabetes; Antioxidants;
D O I
暂无
中图分类号
学科分类号
摘要
Oxidative stress is considered to play an important role in the pathogenesis of diabetes-induced cardiovascular disease (CVD), which is invariably associated with abnormal blood lipid profile, insulin resistance and metabolic syndrome. Stress, smoking, high saturated fat intake as well as low fruit and vegetable intakes have been shown to increase oxidative stress and hyperlipidemia, which increase the predisposition of diabetic subjects to atherosclerosis, stroke and coronary heart disease. The oxidation of low-density lipoprotein by oxidative stress is essential for the development of atherosclerosis, and the reduction in oxidative stress as well as blood glucose and cholesterol is considered critical for the prevention of diabetes-induced CVD. Although epidemiological studies have demonstrated that vitamin C and vitamin E decrease the incidence of coronary heart disease, different clinical trials have failed to support the beneficial effect of these antioxidants. Nonetheless, it has been suggested that natural forms of these vitamins may be more efficacious than synthetic vitamins, and this may explain the inconsistencies in results. Antioxidants, N-acetyl-l-cysteine and resveratrol, have also been shown to attenuate the diabetes-induced cardiovascular complications. It has been indicated that the antioxidant therapy may be effective in a prevention strategy rather than as a treatment for CVD. The evidence presented here supports the view that cardiovascular complications in diabetes may be induced by oxidative stress and appropriate antioxidant therapy may be promising for attenuating the progression of diabetes-induced CVD.
引用
收藏
页码:113 / 121
页数:8
相关论文
共 50 条
  • [31] Prevention of cardiovascular complications in diabetes mellitus: the role of aspirin
    Strizhakov, L. A.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2012, (02): : 94 - 99
  • [32] Approaches to prevention of cardiovascular complications and events in diabetes mellitus
    Coccheri, Sergio
    DRUGS, 2007, 67 (07) : 997 - 1026
  • [33] Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus
    Sergio Coccheri
    Drugs, 2007, 67 : 997 - 1026
  • [34] Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice
    Kurstjens, Steef
    Bouras, Hacene
    Overmars-Bos, Caro
    Kebieche, Mohamed
    Bindels, Rene J. M.
    Hoenderop, Joost G. J.
    de Baaij, Jeroen H. F.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [35] THE EFFECT OF CLOFIBRATE TREATMENT ON DIABETES-INDUCED CARDIOMYOPATHY IN THE RAT
    GRASSBY, PF
    MCNEILL, JH
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 420 - 420
  • [36] Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice
    Steef Kurstjens
    Hacene Bouras
    Caro Overmars-Bos
    Mohamed Kebieche
    René J. M. Bindels
    Joost G. J. Hoenderop
    Jeroen H. F. de Baaij
    Scientific Reports, 9
  • [37] Antioxidants in the prevention of cardiovascular disease
    Páramo, JA
    Orbe, J
    Rodríguez, JA
    MEDICINA CLINICA, 2001, 116 (16): : 629 - 635
  • [38] Dietary antioxidants for cardiovascular prevention
    Giugliano, D
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2000, 10 (01) : 38 - 44
  • [39] Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer
    Emanueli, C
    Salis, B
    Madeddu, P
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A5 - A6
  • [40] Diabetes-induced changes of nitric oxide influence on the cardiovascular action of secretin
    Sitniewska, EM
    Wisniewska, RJ
    Wisniewski, K
    REGULATORY PEPTIDES, 2002, 105 (03) : 163 - 172